| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 861,9 k € | -20.3% | 1,1 M € | +12.7% | 959,8 k € | -6.9% | 1,0 M € | -9.3% | 1,1 M € | +0.1% | 1,1 M € | +20.8% | 940,1 k € | -8.5% | 1,0 M € | +16.7% | 880,4 k € | +4.2% | 844,6 k € | +3.9% | 813,1 k € | -7.7% | 881,2 k € | +20.9% | 728,7 k € | +1.7% | 716,5 k € | +2.5% | 699,1 k € | +2.1% | 684,6 k € | +19.5% | 572,6 k € | -10.3% | 638,5 k € | -32.9% | 951,2 k € | +37.5% | 691,7 k € | |
| EBITDA | 274,4 k € | -43.4% | 485,1 k € | +43.1% | 339,1 k € | -34.6% | 518,2 k € | -8.1% | 564,1 k € | +13.2% | 498,5 k € | +53.1% | 325,6 k € | -27.3% | 447,6 k € | +12.3% | 398,6 k € | +30.5% | 305,4 k € | -4.9% | 321,0 k € | -23.6% | 420,3 k € | +48.2% | 283,6 k € | +9.4% | 259,3 k € | -3.6% | 269,0 k € | -13.5% | 310,8 k € | +15.5% | 269,2 k € | -18.6% | 330,6 k € | -47.3% | 626,8 k € | +54.9% | 404,6 k € | |
| Operating profit | 154,4 k € | -59.4% | 380,0 k € | +50.7% | 252,2 k € | -43.7% | 448,3 k € | -11.9% | 508,7 k € | +10.8% | 459,3 k € | +60.3% | 286,5 k € | -30.2% | 410,5 k € | +14.0% | 360,0 k € | +36.4% | 263,9 k € | -0.6% | 265,5 k € | -16.2% | 316,9 k € | +155.1% | 124,2 k € | +29.3% | 96,1 k € | -14.7% | 112,6 k € | -27.0% | 154,2 k € | +38.9% | 111,1 k € | -34.8% | 170,4 k € | -47.6% | 325,2 k € | +485.5% | 55,5 k € | |
| Profit/loss | 101,4 k € | -59.6% | 251,1 k € | +71.5% | 146,4 k € | -65.7% | 426,6 k € | -0.9% | 430,3 k € | +8.0% | 398,2 k € | +61.8% | 246,1 k € | -30.1% | 352,1 k € | +3.5% | 340,4 k € | +67.3% | 203,4 k € | +8.4% | 187,7 k € | -29.9% | 267,8 k € | +214.6% | 85,1 k € | +73.3% | 49,1 k € | -28.7% | 68,9 k € | -26.1% | 93,2 k € | +54.9% | 60,2 k € | -48.4% | 116,5 k € | -60.5% | 295,0 k € | +2564.6% | 11,1 k € | |
| Equity | 2,8 M € | +3.7% | 2,7 M € | +10.2% | 2,5 M € | +6.3% | 2,3 M € | +13.6% | 2,0 M € | +13.7% | 1,8 M € | +19.9% | 1,5 M € | +6.5% | 1,4 M € | +11.7% | 1,3 M € | +16.8% | 1,1 M € | +6.3% | 1,0 M € | +9.5% | 925,5 k € | +7.9% | 857,7 k € | +11.0% | 772,6 k € | +6.8% | 723,5 k € | +10.5% | 654,6 k € | +16.6% | 561,4 k € | +12.0% | 501,2 k € | +19.0% | 421,3 k € | +85.4% | 227,2 k € | |
| Total assets | 3,3 M € | +5.0% | 3,2 M € | +6.6% | 3,0 M € | -6.3% | 3,2 M € | +10.6% | 2,9 M € | +9.1% | 2,6 M € | +22.7% | 2,1 M € | +3.2% | 2,1 M € | +8.9% | 1,9 M € | +5.6% | 1,8 M € | +11.0% | 1,6 M € | +14.0% | 1,4 M € | +16.8% | 1,2 M € | +3.0% | 1,2 M € | -11.9% | 1,3 M € | +2.1% | 1,3 M € | -1.4% | 1,3 M € | -5.5% | 1,4 M € | -6.7% | 1,5 M € | -17.4% | 1,8 M € | |
| Cash | 1,4 M € | +11.9% | 1,2 M € | +9.9% | 1,1 M € | -32.2% | 1,7 M € | -7.6% | 1,8 M € | -2.6% | 1,9 M € | +43.9% | 1,3 M € | +2.9% | 1,3 M € | +8.2% | 1,2 M € | +7.8% | 1,1 M € | +17.4% | 912,6 k € | +31.2% | 695,3 k € | +81.3% | 383,5 k € | +122.1% | 172,6 k € | -42.4% | 300,0 k € | +45.2% | 206,7 k € | +121.4% | 93,3 k € | +3.0% | 90,6 k € | +54.9% | 58,5 k € | -62.6% | 156,2 k € | |
| Debts | 493,9 k € | +13.8% | 433,9 k € | -11.6% | 490,9 k € | -41.5% | 838,6 k € | +3.0% | 813,8 k € | -0.8% | 820,0 k € | +29.5% | 633,2 k € | -3.7% | 657,7 k € | +2.8% | 639,7 k € | -11.2% | 720,2 k € | +19.1% | 604,5 k € | +22.2% | 494,6 k € | +53.7% | 321,8 k € | -13.1% | 370,5 k € | -35.7% | 576,5 k € | -8.6% | 630,4 k € | -15.1% | 742,6 k € | -12.1% | 845,1 k € | -18.5% | 1,0 M € | -33.2% | 1,6 M € | |
| Staff | 8,6 | 8,6 | 9,5 | 9,1 | 10,8 | 10,9 | 10,4 | 10,7 | 9,6 | 10,4 | 10,1 | 8,8 | 9,5 | 8,8 | 8,6 | 7,4 | 6,3 | 6,7 | 5,6 | 5,4 | ||||||||||||||||||||
Public limited company · Raeren · incorporated on 18/01/1983 · 8,6 ETP
Public limited company profitable and well capitalised. Cash position rising (+11.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PRODIVET PHARMACEUTICALS is a Public limited company incorporated in 1983. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Raeren. It employs on average 8,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette